What You Should Know:
– Peerbridge Health has announced the launch of its landmark COR-INSIGHT Trial, which will validate the screening and diagnostic capabilities of its Peerbridge Cor® ambulatory ECG wearables.
– The trial seeks to revolutionize cardiovascular…
Continue Reading
What You Should Know:
– BrightInsight, Inc., a provider of regulated digital health solutions, has announced an expanded multi-year partnership with Sanofi, a global biopharmaceutical company. This expanded partnership builds on a successful collaboration that…
Continue Reading
Crafting Superior Health Software: IEC 82304-1 ComplianceIEC 82304-1:2016 is tailored to health software products designed to operate on general computing platforms without dedicated hardware. It is aimed at products intended for the market and…
Continue Reading
ISO 14971 is a pivotal standard for risk management in the design and production of medical devices, emphasizing the importance of assessing and controlling risks throughout a product’s lifecycle. Here’s an in-depth look at…
Continue Reading
Background: The rapid growth of digital health apps has necessitated new regulatory approaches to ensure compliance with safety and effectiveness standards. Nonadherence and heterogeneous user engagement with digital health apps can lead to trial…
Continue Reading
Are you a digital health entrepreneur looking to navigate the complex landscape of ISO certifications? Our latest video illustrates the world of ISO and standardization regulations, providing you with the essential roadmap to elevate…
Continue Reading
What You Should Know: Today, Anumana, a nference portfolio company working in collaboration with Mayo Clinic, announced it has received its first 510(k) clearance from the U.S. FDA for its ECG-AI LEF algorithm. – ECG-AI LEF is Anumana’s…
Continue Reading
Erkin Otles – AI Practice Lead – HTD Health What You Should Know: – HTD Health, a New York-based company specializing in virtually-enabled care, EMR integration, and Software as Medical Device (SaMD) design and development, is…
Continue Reading
UK-based digital health tech company Huma has received FDA 510(k) Class II clearance for its configurable disease-agnostic Software as a Medical Device platform, which includes the company’s cardiovascular risk score algorithm. The company, which received…
Continue Reading
Huma Therapeutics has received US Food and Drug Administration (FDA) Class II clearance for its disease-agnostic Software-as-a-Medical-Device (SaMD) platform, enabling companies to launch their own algorithm innovations more quickly to the platform and allowing…
Continue Reading
